Researchers have discovered biomarkers for diverse forms of spinal muscular atrophy (SMA) following applications of ...

Kimberly Westrich, MA, chief strategy officer of the National Pharmaceutical Council, discusses key agenda highlights that ...

As more researchers utilize digital technology to measure mobility in pulmonary arterial hypertension (PAH), a team calls for ...

Two posters presented at the CHEST 2024 annual meeting show that although inhaled treprostinil reduces hospitalizations in ...

Study findings reveals a 1-way relationship between cardiovascular disease and psoriasis, with no impact on other ...

Medical experts discuss how the Inflation Reduction Act’s out-of-pocket prescription drug cost cap, effective in 2025, may ...

Panelists discuss how type 2 inflammatory diseases can lead to potential long-term complications or comorbidities, including airway remodeling in asthma, nasal polyps in chronic rhinosinusitis, skin ...

Hope is on the horizon for patients living with chronic obstructive pulmonary disease (COPD). CHEST 2024 in Boston featured a session highlighting emerging bronchoscopic therapies.

A systematic review analyzing sleep quality and the impact of zinc supplements reveals glaring gaps in knowledge in this area ...

Two posters presented at the CHEST 2024 annual meeting showed that mepolizumab significantly reduces exacerbations in ...

The suggestive evidence should encourage research into the associations to evaluate the association with stronger evidence.

The Heart Failure Society of America (HFSA) annual meeting 2024 was scheduled to showcase groundbreaking research on the ...